Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis The Phase 3 ABTECT trials (Studies 105 and 106) evaluating obefazimod in patients with moderately to severely active ulcerative colitis successfully enrolled 1,275 participants, exceeding the target enrollment of 1,224 by 4%.Top-line results from the 8-week induction trials anticipated in Q3 2025, with 44-week mainten...
Vicat - Q1 2025 Sales Stable sales, –0.2% on an organic basisResilience in France and recovery in SwitzerlandIntegration of Cermix with VPI, strengthening the Group’s position in construction chemicals in FranceWeaker activity in India owing to a fierce competitive environmentConfirmation of FY 2025 guidance Consolidated sales in the first quarter of 2025: (€ million) First-quarter 2025 First-quarter 2024ChangereportedChange lfl*France281270+3.9%–0.1%Europe (excluding France)9592+2.8%+6.5%Americas221222–0.5%+0.8%Asia95120–20.5%–18.8%Mediterranean103104–1.6%+22.6%Africa91101–9.9%–10.1%TOTA...
Vicat - Chiffre d’affaires du 1er trimestre 2025 Chiffre d’affaires stable (-0,2% en organique)Résilience en France et reprise en SuisseIntégration de Cermix dans VPI renforçant la position du Groupe dans les métiers de la chimie du bâtiment en FranceBaisse de l’activité en Inde liée à un environnement concurrentiel tenduConfirmation des perspectives 2025 Chiffre d’affaires consolidé au 1er trimestre 2025 : (en millions d’euros) 31 mars2025 31 mars 2024VariationpubliéeVariationà pcc*France281270+3,9%-0,1%Europe (hors France)9592+2,8%+6,5%Amériques221222-0,5%+0,8%Asie95120-20,5%-18,8%Médite...
In today's Morning Views publication we comment on developments of the following high yield issuers: CeramTec, evoke, SPIE, Fedrigoni, Odido, Profine, Infopro Digital, Banijay, Neopharmed, Vedanta Resources, Nemak, CMA CGM, Ineos, Ineos Quattro, Flos B&B Italia (formerly International Design Group)
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.